Published in Vasc Cell on June 09, 2011
Myxomatous mitral valve disease in dogs: does size matter? J Vet Cardiol (2012) 0.97
The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. Biophys Rev (2015) 0.83
Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats. Dis Model Mech (2012) 0.82
Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med (1995) 26.60
Mechanisms of angiogenesis. Nature (1997) 18.04
The global burden of disease, 1990-2020. Nat Med (1998) 6.50
An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol (1959) 3.16
Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol (1997) 3.02
Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol (2007) 2.69
Angiogenesis in skeletal and cardiac muscle. Physiol Rev (1992) 2.34
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol (2003) 2.26
A new, precise definition of acute myocardial infarction. Cleve Clin J Med (2009) 2.18
Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A (1995) 1.98
Inflammation in the course of early myocardial ischemia. FASEB J (1991) 1.90
Insulin-like growth factor-I receptor-mediated vasculogenesis/angiogenesis in human lung development. Am J Respir Cell Mol Biol (2003) 1.80
MCP-1 mediates TGF-beta-induced angiogenesis by stimulating vascular smooth muscle cell migration. Blood (2006) 1.68
Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes (1997) 1.45
Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res (2006) 1.37
Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem (2000) 1.30
IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab (2002) 1.29
Therapeutic myocardial angiogenesis. Microvasc Res (2007) 1.16
Cardioprotective effect of oleanolic acid on isoproterenol-induced myocardial ischemia in rats. Toxicol Pathol (2007) 1.04
Cardioprotective activity of Ginkgo biloba Phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. Exp Toxicol Pathol (2008) 1.03
Simultaneous administration of insulin-like growth factor-1 and darbepoetin alfa protects the rat myocardium against myocardial infarction and enhances angiogenesis. Clin Transl Sci (2008) 1.00
Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Can J Physiol Pharmacol (1997) 0.98
The multifunctional role of IGF-1 in peripheral nerve regeneration. Neurol Res (2004) 0.97
Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure. Eur J Pharm Sci (2004) 0.91
Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury. Toxicol Pathol (2008) 0.91
Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation. Mol Vis (2011) 0.89
Grape seed proanthocyanidins ameliorates isoproterenol-induced myocardial injury in rats by stabilizing mitochondrial and lysosomal enzymes: an in vivo study. Life Sci (2007) 0.88
Therapeutic angiogenesis in ischemic heart disease: gene or recombinant vascular growth factor protein therapy? Curr Gene Ther (2003) 0.87
Serum growth factors and neuroprotective surveillance: focus on IGF-1. Mol Neurobiol (2000) 0.86
Stimulation of functional vessel growth by gene therapy. Integr Biol (Camb) (2010) 0.83